Transcript Intelligence: Belite Bio at Leerink Global Healthcare Conference ($173.78, +0.48)
Belite Bio reports Q4 EPS ($0.70) vs FactSet ($0.55) [8 est, ($0.66)-(0.43)] ($190.30, 0.00)
StreetAccount Summary - US equity offerings expected to price for Tuesday, 03-Feb
Powered by FactSet Research Systems Inc.